Macquarie Group Ltd. Sells 26,129 Shares of Merit Medical Systems, Inc. (MMSI)

Macquarie Group Ltd. trimmed its holdings in Merit Medical Systems, Inc. (NASDAQ:MMSI) by 2.3% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,096,328 shares of the medical instruments supplier’s stock after selling 26,129 shares during the quarter. Macquarie Group Ltd. owned approximately 2.19% of Merit Medical Systems worth $46,429,000 at the end of the most recent quarter.

Several other institutional investors have also made changes to their positions in MMSI. LS Investment Advisors LLC increased its stake in Merit Medical Systems by 8.1% in the 2nd quarter. LS Investment Advisors LLC now owns 3,694 shares of the medical instruments supplier’s stock valued at $141,000 after buying an additional 277 shares during the period. Advisors Asset Management Inc. increased its stake in Merit Medical Systems by 28.2% in the 2nd quarter. Advisors Asset Management Inc. now owns 3,723 shares of the medical instruments supplier’s stock valued at $142,000 after buying an additional 820 shares during the period. Ameritas Investment Partners Inc. increased its stake in Merit Medical Systems by 20.9% in the 2nd quarter. Ameritas Investment Partners Inc. now owns 4,272 shares of the medical instruments supplier’s stock valued at $163,000 after buying an additional 738 shares during the period. SG Americas Securities LLC acquired a new position in Merit Medical Systems in the 3rd quarter valued at $189,000. Finally, Riverhead Capital Management LLC increased its stake in Merit Medical Systems by 67.7% in the 2nd quarter. Riverhead Capital Management LLC now owns 5,198 shares of the medical instruments supplier’s stock valued at $198,000 after buying an additional 2,098 shares during the period. 89.47% of the stock is currently owned by institutional investors and hedge funds.

In other Merit Medical Systems news, Director Kent W. Stanger sold 670 shares of the stock in a transaction that occurred on Thursday, September 14th. The shares were sold at an average price of $42.06, for a total value of $28,180.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 5.00% of the stock is currently owned by corporate insiders.

Several brokerages have issued reports on MMSI. Canaccord Genuity reissued a “buy” rating and issued a $45.00 price objective on shares of Merit Medical Systems in a research note on Sunday, October 8th. Zacks Investment Research cut shares of Merit Medical Systems from a “buy” rating to a “hold” rating in a research note on Tuesday, October 3rd. SunTrust Banks, Inc. set a $47.00 price target on shares of Merit Medical Systems and gave the stock a “buy” rating in a research note on Thursday, November 16th. Piper Jaffray Companies reaffirmed a “buy” rating and set a $45.00 price target on shares of Merit Medical Systems in a research note on Friday, July 28th. Finally, Raymond James Financial, Inc. reaffirmed an “outperform” rating and set a $44.00 price target on shares of Merit Medical Systems in a research note on Monday, August 28th. One equities research analyst has rated the stock with a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the company. The stock presently has an average rating of “Buy” and an average price target of $42.02.

Merit Medical Systems, Inc. (MMSI) traded up $1.30 during midday trading on Tuesday, hitting $41.90. 322,300 shares of the stock were exchanged, compared to its average volume of 389,328. The firm has a market cap of $2,038.07, a P/E ratio of 31.97, a P/E/G ratio of 2.75 and a beta of 1.20. Merit Medical Systems, Inc. has a one year low of $23.25 and a one year high of $45.50. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.43 and a current ratio of 2.78.

Merit Medical Systems (NASDAQ:MMSI) last posted its earnings results on Wednesday, October 25th. The medical instruments supplier reported $0.32 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.30 by $0.02. The firm had revenue of $179.30 million during the quarter, compared to the consensus estimate of $181.28 million. Merit Medical Systems had a net margin of 4.06% and a return on equity of 9.86%. The company’s revenue was up 14.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.26 EPS. analysts expect that Merit Medical Systems, Inc. will post 1.27 EPS for the current fiscal year.

WARNING: This article was posted by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this article on another site, it was illegally copied and reposted in violation of US and international copyright legislation. The correct version of this article can be read at https://sportsperspectives.com/2017/11/21/macquarie-group-ltd-sells-26129-shares-of-merit-medical-systems-inc-mmsi.html.

About Merit Medical Systems

Merit Medical Systems, Inc is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices.

Institutional Ownership by Quarter for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply